Exploring the risk factors and prognosis of transverse myelitis in systemic lupus erythematosus.

Minhui WangZiqian WangLi ZhangJiuliang ZhaoDi WuJing LiQian WangJinmei SuDong XuShangzhu ZhangMeng Tao LiXiaofeng Zeng

Published in: Therapeutic advances in chronic disease (2022)

The positive anti-Ro/SSA antibodies and increased ESR may be associated with the presence of SLE-TM. An initial presentation with severe myelitis and hypoglycorrhachia appear to be predictors of a poor neurological outcome. Early steroid pulse therapy may improve the prognosis.

Keyphrases

risk factors
systemic lupus erythematosus
blood pressure
early onset
disease activity
rheumatoid arthritis
mesenchymal stem cells
subarachnoid hemorrhage
smoking cessation
replacement therapy